US Stem Cell Inc (USRM)

[emit]

Good comprehensive read of overall industry. Yup we have proved POC. I don't see that company tthat has the SC mesh patch we DDd while back.

“What the small companies need to do is show proof of concept. You have to hit your endpoints,” said Marban.
There is a desperate need for new therapies to treat heart failure, a chronic condition that prevents the heart from pumping blood as it should. The number of American adults with the disease could top 8 million by 2030, up from 5.7 million in 2012, while the cost of treatment could more than double, from $31 billion to $70 billion.
Each firm is taking a different approach to reach the same goal: bolstering the deteriorated muscle.''

http://news.heart.org/clinging-to-the-promise-of-heart-stem-cell-therapy/

emit...